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Abstract
Background: We conducted a study to identify Rickettsia, Coxiella, Leptospira, Bartonella, and Chikungunya virus
infections among febrile patients presenting at hospitals in Bangladesh.
Methods: We collected blood samples from patients at six tertiary hospitals from December 2008 to November
2009 and performed laboratory tests at the United States Centers for Disease Control and Prevention (CDC).
Results: Out of 720 enrolled patients, 263 (37%) were infected with Rickettsia; 132 patients had
immunofluorescence antibody titer >64 against spotted fever, 63 patients against scrub typhus fever and 10
patients against typhus fever. Ten patients were identified with Coxiella. We isolated Leptospira from two patients
and Bartonella from one patient. Ten patients had antibodies against Chikungunya virus. The proportion of patients
who died was higher with rickettsial fever (5%) compared to those without a diagnosis of rickettsial infection (2%).
None of the patients were initially diagnosed with rickettsial fever.
Conclusions: Rickettsial infections are frequent yet under-recognized cause of febrile illness in Bangladesh. Clinical
guidelines should be revised so that local clinicians can diagnose rickettsial infections and provide appropriate drug
treatment.
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Background
In Bangladesh, dengue, malaria, typhoid fever and influ-
enza like illnesses are common causes of febrile illness
[1–4]. Other agents might be important causes of fever
but are rarely considered by clinicians and often under-
diagnosed.
Rickettsial pathogens are gram-negative bacteria ca-
using fever and rash, usually transmitted to humans by
contamination of bite sites or skin abrasions with Rick-
ettsia-containing flea feces or directly by the bite of
ticks [5]. C. burnetii, an obligate intracellular and small
gram-negative bacterium, has been classified in the
Rickettsiales order due to its recovery from ticks and
its inability to grow in axenic medium. However,
according to recent investigations based on 16S rRNA
sequence, Coxiella genus belongs to the gamma subdiv-
ision of Proteobacteria and Rickettsia genus to the
alpha-1 subgroup of Proteobacteria [6]. Recently 40
rickettsial cases were detected in a hospital based study
in Mymensingh, a northern district in Bangladesh.
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Suspected rickettsial cases were enrolled from 2003 to
2005 on the basis of fever, rash and those patients who
initially were diagnosed as typhoid and malaria cases
but were nonresponsive to ciprofloxacin and anti-
malarial therapy. Rickettsial diagnosis was confirmed by
the Weil-Felix test [7].
Leptospirosis is a zoonotic infectious disease trans-
mitted from animals to humans through contact of
mucous membranes with water or soil contaminated
with urine of infected animals [8]. Sixty-three le-
ptospirosis patients were detected through serological
evaluation in a study at two hospitals in Dhaka city
in 2001 [9]. This study emphasized the need for
further information on wide geographical context in
Bangladesh.
Bacteria of the genus Bartonella cause human and ani-
mal disease and are transmitted between animals or is
communicable to humans through diverse arthropod vec-
tors (i.e. sand flies for B. bacilliformis or human body lice
for B. Quintana) [10]. Many new Bartonella species have
been identified in Indonesia, the Philippines, Singapore,
and Thailand [10]. In addition, a study conducted in
Dhaka, Bangladesh revealed a high prevalence of Barto-
nella in three mammalian species: lesser bandicoots, black
rats, and house shrews [11]. Therefore, communities in
Bangladesh could also be at risk of acquiring Bartonella
infection.
Chikungunya is a viral disease, transmitted by Aedes
aegypti and Aedes albopictus mosquitoes and ma-
nifested with incapacitating arthralgia [12]. In early
2006, the World Health Organization (WHO) re-
ported a large Chikungunya outbreak in several In-
dian Ocean islands including the Maldives, Mauritius,
Madagascar, Mayotte, Seychelles and La Reunion as
well as in 151 districts located in ten states along the
coastal region of India [12]. Dengue and Chikungunya
viruses share the same vectors, similar symptoms and
geographical distribution [13]; still we know little
about the epidemiology of Chikungunya virus in
Bangladesh [14].
While these studies have indicated the circulation of
Rickettsia, Leptospira, Bartonella and Chikungunya virus
in Bangladesh, they were often carried out in a limited
setting and with a small sample size. It is also unknown
how widespread these infections are and about their
virulence for causing serious illnesses. We conducted a
12 month hospital-based study to determine the preva-
lence of various pathogens causing acute febrile illnesses
in Bangladesh. We previously reported the 69 dengue
fever and 4 malaria cases identified from this study [15].
This paper evaluates the distribution of Rickettsia,
Coxiella, Leptospira, Bartonella, and Chikungunya virus




The study setting, patient enrollment and sample collec-
tion method have been described previously [15]. The
study period was from December 2008 to November
2009. Patients from inpatient and outpatient department
of six tertiary teaching hospitals, from each division in
Bangladesh, participated in this study.
Case definition
We defined febrile cases as patients who presented with
fever or a complaint of fever of >38 °C with onset
within the preceding 10 days. We excluded any patient
who developed a new onset of fever after 72 h of
hospitalization. In addition, the study team excluded fe-
brile patients with pneumonia, urinary tract infections,
skin and soft tissue infections or a confirmed laboratory
diagnosis of an infection other than the pathogens of
interests, such as typhoid fever.
Sample size and sampling procedure
We assumed that 200,000 people sought care for febrile
illness at these hospitals per year, and if the real preva-
lence of infection with one of these organisms was
0.75%, then a sample of 675 would provide a 95% prob-
ability of identifying point prevalence between 0.1% and
1.4%. We aimed to collect 10 specimens from each
hospital in each month [15]. This would provide 720
specimens in a year. Of these 10 specimens from each
hospital, we collected 5 from the adult medicine unit
and 5 from the pediatric unit (<14 years of age).
Case enrollment
Two consecutive days in each month, field assistants
and laboratory technicians from icddr,b (International
Centre for Diarrheal Diseases Research, Bangladesh) vis-
ited the selected hospitals to assist the locally recruited
study physicians. The study physicians first looked for
inpatients who met the case definition. After obtaining
consents/assents from the participants, the study phys-
ician enrolled up to 10 participants. If the study phys-
ician was unable to enrol samples from 10 inpatients
then s/he collected the rest of the samples from outpa-
tients using the same case definition.
Data collection
The study physicians collected study-related demographic
and clinical information in a standardized assessment
form. Laboratory technicians attempted to follow-up by
cell phone with all patients two months after their initial
enrollment collecting information regarding recovery, re-
sidual illnesses and illnesses among the family members,
locality, and selected socio-economic variables.
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Specimen processing
Laboratory technicians inoculated Ellinghausen, McCul-
lough, Johnson, and Harris (EMJH) medium with 3 drops
of fresh whole human blood from the collected sample at
the study hospital following sample collection. Thereafter,
inoculated media were kept in an incubator at 30 °C at the
icddr,b laboratory in Dhaka and shipped every two months
for Leptospira laboratory analysis at the CDC. Laboratory
technicians separated one third of the total blood in
EDTA tube for real time polymerase chain reaction (PCR)
for rickettsial DNA detection. The rest of the blood
sample was dispensed into a sterile test tube which was
centrifuged in the study location to get the blood cell con-
centrate and serum separated for Bartonella culture,
enzyme-linked immuno sorbent assays (ELISA) and PCR
tests. The blood cell concentrate was transferred into ster-
ile 2 ml cryovials for Bartonella laboratory tests. Two ali-
quots of serum were preserved in screw capped cryovials:
one for Rickettsia and Coxiella serological tests and one
aliquot for Chikungunya virus serological tests.
Laboratory tests
At the CDC, Leptospira species were isolated from the
culture media. In addition, serovar classifications of iso-
lated Leptospira species were performed by pulsed field
gel electrophoresis (PFGE) [16]. For Bartonella testing,
blood cell concentrate from each patient were inoculated
into Bartonella/alpha-Proteobacteria growth medium
(BAPGM) and incubated aerobically at 35 °C with 5%
CO2 for seven days. DNA was extracted from this pre-
enrichment using the QIAamp DNA mini kit (Qiagen,
Chasworth, CA) according to manufacturer’s instruc-
tions, and analyzed using polymerase chain reaction
(PCR) assays targeting specific regions in transfer-
messenger RNA (ssrA), citrate synthase (gltA) gene, and
16S-23S rRNA internal transcribed spacer (ITS) [17].
Chikungunya laboratory tests were performed only for
99 patients who had both fever and joint pain. Chikun-
gunya antibody was detected by ELISA and followed by
a plaque reduction neutralization test (PRNT) [18].
PRNT was performed for four related alphaviruses, Ross
River virus, Sindbis virus, Getah virus, and Bebaru virus;
these viruses had previously been identified in Asia and
thus were considered the most likely viruses to generate
related antibodies. The immuno flourescence antibody
test (IFAT) and PCR laboratory assays were also per-
formed for all samples to detect spotted fever and typhus
group Rickettsia [19, 20]. However, ELISA was performed
for the 360 samples collected from December 2008 to
May 2009 and IFAT for the remaining 360 samples col-
lected from June to November 2009 for scrub typhus
group Rickettsia. Samples collected from June to Novem-
ber 2009 were analysed for Coxiella burnetii specific anti-
body by ELISA assay.
Diagnostic definitions
A patient was considered to be a case of leptospirosis if
his/her blood culture of EMJH media grew Leptospira.
Spotted fever, typhus group or scrub typhus group Rickett-
sia was diagnosed with a positive IFAT test at a titer >64
[21, 22] or for scrub typhus an ELISA positive test result.
Coxiella burnetii was diagnosed by a positive ELISA test
result. A febrile patient was diagnosed with bartonellosis
by positive blood culture. Chikungunya fever was diag-
nosed by the presence of Chikungunya virus specific IgM
or IgG antibody and PRNT with a titer ≥320 in patients
presenting with both fever and joint pain.
Data analysis
The primary outcome was the descriptive statistics of pa-
tients presenting with fever without confirmed laboratory
diagnosis at six facilities considering the specific infections
of interest. We performed principle component analysis
based on 10 owned assets of the households, as well as
sanitation facilities, drinking water sources, cooking fuels
and household construction and divided this wealth index
into 5 quintiles [23]; we presented the quintiles by our
pathogens of interest.
Ethical considerations
The study physicians obtained written consent from the
adult participants and parents of children under 7 years
of age and assents from children between 7 and 17 years
old. The Ethical Review Committee (ERC) of icddr,b
reviewed and approved the study protocol.
Results
We enrolled 720 participants with a mean age of
19 years. Out of 462 inpatients, 232 were from the medi-
cine unit; 147 (32%, N = 462) were female. Among 258
outpatients, 132 were from the medicine unit and 121
(47%, N = 258) were female. In total, 176 (24%) were
under five years of age and 392 (54%) were less than
18 years of age.
Out of 720 febrile patients evaluated, 263 (37%) had
laboratory results suggesting infection with one or more
rickettsial agents (Table 1). Among 462 hospitalized
patients, 150 (32%) had evidence of rickettsial infections.
Ten patients (1%, n = 720) had evidence of rickettsial
typhus group infection, 132 patients (18%, n = 720) for
spotted fever, and 63 patients (18%, n = 360) had a scrub
typhus fever IFA titer of more than 64 (Table 2).
Rickettsial illnesses were identified throughout
Bangladesh, most commonly from patients tested from
Rajshahi (n = 64, 53%) and least commonly from Barisal
(n = 34, 28%) (Fig. 1). Evidence of typhus group, spotted
fever group and scrub typhus group Rickettsia illnesses
were detected throughout the year (Fig. 2). Among 34 pa-
tients having positive scrub typhus IFA titer >512, only
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two were diagnosed in November. Out of the 360 tested
samples collected from June to November 2009, 10 were
seropositive for Coxiella; 7 (70%) of these patients were
from public hospitals and 6 (86%) of them were admitted
to the inpatient unit. Three Coxiella-positive patients were
identified from Rajshahi and Barisal equally and mostly in
August (3) (Figs. 1 and 2).
Fever, headache, bodyache, muscle and joint pain were
more frequent clinical presentations among the rickett-
sial patients. However, rash was confirmed on physical
examination in only 2% of spotted fever group and 1% of
scrub typhus group rickettsial illnesses.
Among two identified leptospirosis cases, one was a
42 year-old man from Kishoreganj with a history of
intermittent fever and headache and a neutrophil count
of 86%. The other case was a 7 year-old boy from Barisal
with history of continuous fever, signs of jaundice and a
lymphocyte count of 41% (Table 3). The Leptospira iso-
late from Barisal was L. borgpetersenii serovar Ceylonica,
a member of serogroup Javanica, with a similar PFGE
pattern to serovars Dehong, 52-73, and 27-75. The sec-
ond Leptospira isolate was of serogroup Sejroe and by
PFGE it was L. borgpetersenii serovar Dikkeni.
One 9 year-old male outpatient from Kishoreganj pre-
sented with a one day history of continuous fever with-
out rash or travel history with concomitant diagnosis of
dengue fever (15) and Bartonella infection (Table 3).
The blood sample enriched in liquid BAPGM medium
was PCR positive for Bartonella with all three targets
(gltA, ssrA, and ITS) and sequencing analyses of ssrA
and ITS demonstrated that it belonged to Bartonella
elizabethae, a rat-associated Bartonella species.
Ninety-nine samples from people who had a history of
both fever and joint pain were tested for antibodies
against Chikungunya virus. Ten samples were positive
using IgG ELISA tests; one was positive to both IgG and
IgM. The IgG ELISA results were confirmed by PRNT
results with all titers on positive samples greater than or
equal to 320. In addition, all PRNT results were negative
for 4 related alphaviruses.
The case fatality rate among patients with rickettsial
infections was 5% (n = 10, N = 191) (Table 4). The case
fatality rate for patients without a diagnosis of Rickettsia
was 2% (n = 7, N = 357). Among the patients who died
with evidence suggesting a Rickettsia infection, five pa-
tients had scrub typhus titers, three were spotted fever
positive, and two had positive test results for both
agents. Co-infection appeared higher among spotted
fever and scrub typhus group positive patients with a
proportion of 6% (n = 45, N = 720). Among these, five
patients (11%, n = 5, N = 45) were co-infected with either
dengue or Chikungunya viruses (Table 5). Febrile pa-
tients commonly presented with intermittent fever.
Fever was associated with chills or sweating and sub-
sided either without taking any medication or with only
antipyretic medication such as paracetamol (Table 6).
Out of 187 patients later identified with Rickettsia
from our laboratory testing, 49 (26%) febrile patients
Table 1 Distribution of pathogens among the febrile patients*
ELISA screening
[N = 360]†




PCR [N = 720]§ Culture [N = 720]
Rickettsial infections Typhus group (N = 720) NT 10 (1) NA 1 (0.1) NT
Spotted fever group (N = 720) NT 132 (18) NA 0 NT
Scrub typhus group (N = 360) NT 63 (18) NA 2 (1) NT
Scrub typhus group (N = 360) 107 (30) NT NA NT NT
Coxiella burnetii (N = 360) 10 (3) 0 NA 0 NT
Leptospirosis (N = 720) NT NA NA NT 2 (0.3)
Chikungunya fever (N = 99) 10 (10) NA 10 (10) NT NT
Bartonella infections (N = 720) NT NA NA NT 1 (0.1)
NT = not tested, NA = not applicable
* Values are n (%) unless otherwise indicated
† ELISA for Chikungunya virus were screened for 99 patients
‡ IFAT to detect Coxiella were performed for patients with positive or equivocal ELISA results
§ PCR for scrub typhus and Coxiella were performed for 360 patients
Table 2 Presentation of rickettsial species according to the titer of Indirect Immunofluorescence Assay (IFA) tests*
Species 32 titer 64 titer 128 titer 256 titer 512 titer or more
Typhus group (N = 720) 11 (2) 12 (2) 6 (1) 2 (0.3) 2 (0.3)
Spotted fever group (N = 720) 163 (23) 117 (16) 84 (12) 43 (6) 5 (1)
Scrub typhus group (N = 360) 13 (4) 5 (1) 14 (4) 15 (4) 34 (9)
* Values are n (%) unless otherwise indicated
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Fig. 1 Map of Bangladesh showing the distribution of febrile patients with confirmed aetiologies
Faruque et al. BMC Infectious Diseases  (2017) 17:141 Page 5 of 12
were initially diagnosed clinically with enteric fever, 26
(14%) patients with respiratory tract infection (RTI), 14
(7%) patients with viral fever, and 12 (6%) with malaria on
admission. Among the 10 patients who died and were
positive for rickettsial infection, two were diagnosed with
malaria, one with meningo-encephalitis, and one with
hepatitis. The remaining five patients were diagnosed with
either fever with acute liver failure, febrile convulsion,
cerebral palsy with bronchopneumonia, cerebrovascular
disease (CVD) with renal impairment or bronchogenic
carcinoma and no diagnosis was reported for one patient.
Out of 242 rickettsial-positive patients, 41 (17%) were
treated exclusively with ceftriaxone, 34 (14%) with azithro-
mycin alone, 22 (9%) with ciprofloxacin only, 21 (9%) with
amoxicillin, and 13 (5%) were treated with levofloxacin.
Doxycycline was prescribed in only one patient and tetra-
cycline in two patients. Out of ten deaths, an antibiotic
was prescribed for only six of them; three of them were
prescribed paracetamol and one ibuprofen.
Discussion
Rickettsial disease is widespread in Bangladesh. Patients
with evidence of a rickettsial infection had a higher case
fatality ratio compared to the febrile patients with other
infectious aetiologies. Other causes of acute febrile ill-
ness such as leptospirosis (0.3%), bartonellosis (0.1%)
and Chikungunya fever with joint pain (10%) were also
identified from Bangladesh.
An earlier study on rickettsial disease in Bangladesh
was conducted at Mymensingh Medical College Hospital
where 40 rickettsial cases were described including 48%
with scrub typhus and 40% with Indian tick typhus, a
member of the spotted fever group. However, this was a
small study with patients limited to only one district,
and only selected rickettsia-positive cases were evaluated
without any routine surveillance or standard case defin-
ition. In addition, the Weil–Felix agglutination reaction
test that was used for diagnosis of rickettsial cases, has
low sensitivity and specificity. Moreover, this test was
performed in various local laboratories not at reference
laboratories [7].
A high titer for scrub typhus suggests active/recent in-
fection and is likely the cause of the febrile illness in the
patients diagnosed with rickettsial fever (Table 2). Low
titers are more indicative of a past exposure although
the titer will also be low during the early stage of an in-
fection. The results presented here are most consistent
with active scrub typhus infections at the time of the fe-
brile illness [24, 25]. The temporal distribution suggests
that scrub typhus infections occur throughout the year;
however, this might be due to the detection of active in-
fections in the rainy seasons and detection of past rainy-
season infections during the winter months. Active in-
fections had been generally reported during the summer
rainy season when the trombiculid mites are most abun-
dant and active [26–30]. Similarly, the year-round distri-
bution of typhus group and spotted fever group [31–33]
presenting with a lower titer suggests past exposure for
most of these rickettsial cases (Fig. 2); the proportion of
patients identified with typhus group and having an IFA
titer below 512 was 80% and for spotted fever group
96%, and for an IFA titer at 128 was 60% for typhus
group and 64% for spotted fever group. The high pro-
portion of low titers (i.e., 32 and 64) in both these
groups suggests that these are not active infections but
might be explained by prior exposure to infections
among these febrile patients (Table 2).
The case fatality rate of rickettsial fever has been re-
ported to be up to 30-35% if untreated [25, 34], the age
adjusted Rocky Mountain spotted fever (RMSF) case fa-
tality rate ranged from 10 to 25% [35], and even with
treatment, 5% of the cases died [36]. Likewise, scrub ty-
phus mortality of 10–50% has been reported in un-
treated patients [37]. This higher mortality is often due
to delayed consultation with physicians or failure to pre-
scribe appropriate antibiotics [25, 34, 38]. In addition,
the diagnosis could be difficult due to absence of rash or
eschar or under-reporting of antecedent arthropod vec-
tor bite [35]; the clinical parameters in our study did not
support separating the rickettsial cases based on any
clinical criteria. Similarly, we observed higher case fatal-
ity ratio among patients suffering from rickettsial fever
compared to other febrile illnesses in this study. Rickett-
sial diagnoses were missed in these hospitals likely due
to low index of clinical suspicion and inadequate diag-
nostic facilities. Only one rickettsial patient in this study
was treated with doxycycline, the drug of choice for rick-
ettsial infection of both adults and children [19].
Earlier studies in urban [9, 39] and rural [40]
Bangladesh identified Leptospira infections. Eight per-
cent probable and definitive leptospirosis cases were
detected through microscopic agglutination tests
(MAT) on 584 febrile patients from Kamalapur, a low
income area in Dhaka city. On the other hand, 33% of
58 febrile cases with/without jaundice were diagnosed
as leptospirosis patients using a microcapsule agglutin-
ation test (MCAT) from Sirajganj, a rural district in
Bangladesh. Additionally, in a hospital-based study,
18% of 359 dengue negative serum samples were con-
firmed as PCR positive leptospirosis cases from Dhaka
Medical College Hospital and Holy Family Red Cres-
cent Hospital in 2001 [9]. However, we confirmed only
two leptospirosis cases using EMJH culture media
throughout Bangladesh for a period of one year. The
earlier studies were based on highly sensitive sero-
logical tests [41–43], so our culture-based approach
underestimated the contribution of Leptospira to the
burden of febrile illness in these hospitals.
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Table 3 Characteristics of the study participants*








(N = 1)Typhus group
Rickettsia (N = 10)
Spotted fever group
Rickettsia (N = 132)
Scrub typhus group
Rickettsia (N = 170)
Median (interquartile
range) 14(5,30)
18(14,35) 17.5 (7,30) 30(12,45) 21.5(14,36) 24.5(7,42) 14(10,35) 9
Age category
0-10 years (318) 2 (1) 50 (16) 39 (12) 2 (1) 1 (0.3) 3 (1) 1 (0.3)
11-20 years (121) 4 (3) 24 (20) 24 (20) 3 (2) 0 3 (2) 0
21-30 years (117) 1 (1) 26 (22) 28 (24) 1 (1) 0 0 0
31-40 years (62) 2 (3) 17 (27) 30 (48) 2 (3) 0 4 (6) 0
> 40 years (102) 1 (1) 15 (15) 49 (48) 2 (2) 1 (1) 0 0
Below 5 years (176) 1 (1) 28 (16) 13 (7) 1 (1) 0 1 (1) 0
Below 18 years (392) 4 (1) 66 (17) 55 (14) 4 (1) 1 (0.3) 6 (2) 1 (0.3)
Male (452) 7 (2) 76 (17) 90 (20) 6 (1) 2 (0.4) 4 (1) 1 (0.2)
Inpatient medicine
(232)
5 (2) 29 (13) 72 (31) 7 (3) 1 (0.4) 3 (1) 0
Inpatient paediatrics
(230)
1 (0.4) 32 (14) 34 (15) 2 (1) 1 (0.4) 4 (2) 0
Wealth index‡
[N = 557]§
(N = 5) (N = 94) (N = 130) (N = 8) (N = 1) (N = 6) (N = 1)
Lowest (110) 1 (1) 18 (16) 32 (29) 2 (2) 0 0 0
Second (110) 0 22 (20) 37 (34) 2 (2) 1 (1) 3 (3) 0
Middle (106) 0 17 (16) 18 (17) 2 (2) 0 2 (2) 1 (1)
Fourth (114) 1 (1) 18 (16) 24 (21) 2 (2) 0 0 0
Highest (117) 3 (3) 19 (16) 19 (16) 0 0 1 (1) 0
* Values are n (%) unless otherwise indicated; Mean is reported along with ± Standard deviation
† Rickettsia test results categorized as positive cases who had IFAT titer of more than 64 or scrub typhus ELISA positive. Rickettsial species included typhus group,
spotted fever group and scrub typhus group. In total, 312 rickettsial infections (typhus group [n = 10], spotted fever group [n = 132] and scrub typhus group
[n = 170]) identified in 263 patients
‡ Quintile 1 to 5 of wealth index is based on principle component analysis on the owned 10 assets of the households, sanitation facilities, drinking water sources,
cooking fuels and household construction
§ We could follow up in total 557 out of 720 febrile patients; 5 out of 10 typhus group, 94 out of 132 spotted fever group, 130 out of 170 scrub typhus group, 8
out of 10 Coxiella burnetii cases, 1 out of 2 leptospirosis, 6 out of 10 Chikungunya and one bartonellosis patients
Fig. 2 Presentation of pathogens among the febrile patients throughout the year from December 2008 to November 2009. * The laboratory tests
for Coxiella burnetii (N = 360) were not performed for 360 samples collected from December 2008 to May 2009
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Table 4 Clinical presentation and outcome*








(N = 1)Typhus group
Rickettsia (N = 10)
Spotted fever group
Rickettsia (N = 132)
Scrub typhus group
Rickettsia (N = 170)
Symptoms
Fever 10 (100) 132 (100) 170 (100) 10 (100) 2 (100) 10 (100) 1 (100)
Headache 7 (70) 66 (50) 117 (69) 5 (50) 1 (50) 3 (30) 0
Bodyache 3 (30) 54 (41) 84 (49) 4 (40) 0 2 (20) 0
Muscle pain 0 23 (17) 38 (22) 0 0 0 0
Joint pain 0 19 (14) 46 (27) 0 0 10 (100) 0
Rash 0 1 (1) 2 (1) 0 0 0 0
Bleeding 0 2 (2) 2 (1) 0 0 0 0
Retro-orbital pain 0 5 (4) 13 (8) 0 0 0 0
Eye-redness 0 5 (4) 5 (3) 0 0 0 0
Jaundice 0 4 (3) 8 (5) 2 (20) 0 0 0
Neck stiffness 0 2 (2) 4 (2) 0 0 0 0
Low urinary output 0 5 (4) 3 (2) 0 0 1 (10) 0
Physical findings
Mean Pulse rate 101 ± 19 100 ± 21 92 ± 21 96 ± 19 100 ± 0 95 ± 19 130 ± 0
Mean Respiratory rate 20 ± 6 26 ± 12 23 ± 11 22 ± 9 28 ± 3 26 ± 7 26 ± 0
Mean Systolic BP 115 ± 16 108 ± 17 110 ± 19 101 ± 12 110 ± 14 103 ± 11 110 ± 0
Mean Diastolic BP 74 ± 8 71 ± 10 71 ± 12 63 ± 9 60 ± 0 68 ± 9 60 ± 0
Mean Temperature 99.7 ± 1.5 100.2 ± 1.7 100.1 ± 1.5 100.1 ±
1.3
102.5 ± 2.1 99.8 ± 0.6 99 ± 0
Anemia 1 (10) 21 (16) 34 (20) 3 (30) 0 2 (20) 0
Jaundice 0 3 (2) 6 (4) 1 (10) 1 (50) 0 0
Edema 0 4 (3) 6 (4) 0 0 0 0
Rash 0 2 (2) 2 (1) 0 0 0 0
Neck rigidity 0 2 (2) 5 (3) 0 0 0 0
Dehydration 0 13 (10) 23 (14) 2 (20) 0 0 0
Laboratory findings





Mean Neutrophil percent 63 ± 8 68 ± 14 66 ± 15 67 ± 12 71 ± 21 - -





Mean ESR 42 ± 20 40 ± 20 48 ± 29 34 ± 10 58 ± 3 28 ± 0 -
Outcome [N = 557]† (N = 5) (N = 94) (N = 130) (N = 8) (N = 1) (N = 6) (N = 1)
Recovery‡ 5 (100) 59 (63) 76 (58) 6 (75) 1 (100) 3 (50) 1 (100)
Death 0 5 (5) 7 (5) 2 (25) 0 0 0
Mean recovery days§ 11 ± 7 17 ± 12 18 ± 10 16 ± 12 18 ± 0 28 ± 9 16 ± 0
Similar Concurrent illness in
the family member
0 11 (12) 8 (6) 0 0 2 (33) 0
* Values are n (%) unless otherwise indicated; Mean is reported along with ± Standard deviation
† We could follow up 5 out of 10 typhus group, 94 out of 132 spotted fever, 130 out of 170 scrub typhus group, 8 out of 10 Coxiella burnetii cases and 1 out of 2
leptospirosis, 6 out of 10 Chikungunya and one bartonellosis patients. The remaining patients were not accessible or available on phone follow-up
‡ Recovery is defined as presence of no signs or symptoms of illness or any disability
§ The mean recovery days along with SD indicates how long it took time for the febrile patients to recover from the illnesses
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We identified Leptospira borgpetersenii serovar Ceylo-
nica (serogroup Javanica) and L. borgpetersenii serovar
Dikkeni (serogroup Sejroe) in this study. These sero-
vars were originally isolated in nearby geographic re-
gions [44–47].
A zoonotic study in 2003 in Bangladesh reported
that 43% of 201 mammals were infected with Barto-
nella and most of the identified organisms resembled
B. elizabethae [11]. We confirmed one Bartonella (B.
elizabethae) case by culture in this study. Although
our culture based approach allowed us to characterize
the isolate, it almost certainly underestimated the
contribution of Bartonella to febrile illness in these
hospitals [48].
A study was conducted by IEDCR and icddr,b to identify
Chikungunya fever in urban Dhaka in 2006 with 175
blood samples [49]. The study site was limited to Dhaka,
the sample size was small and did not identify any
Table 6 Pattern of fever among the febrile patients*
Typhus group
Rickettsia (N = 10)
Spotted fever group
Rickettsia (N = 132)
Scrub typhus group










Remittent 2 (20) 23 (17) 25 (15) 0 0 0 0
Intermittent 8 (80) 72 (55) 93 (55) 9 (90) 1 (50) 7 (70) 0
Continuous 0 33 (25) 44 (26) 1 (10) 1 (50) 3 (30) 1 (100)
Fever subsided with:
Paracetamol 3 (30) 81 (61) 113 (66) 4 (40) 0 8 (80) 0
Analgesics 0 1 (1) 2 (1) 0 0 1 (10) 0
Both 0 0 0 0 0 0 0
No medication 7 (70) 50 (38) 55 (32) 6 (60) 2 (100) 1 (10) 1 (100)
Fever associated with:
Chills 0 12 (9) 22 (13) 1 (10) 1 (50) 2 (20) 0
Sweating 0 17 (13) 22 (13) 2 (20) 0 6 (60) 0
Both 0 2 (2) 5 (3) 0 0 0 0
* Values are n (%) unless otherwise indicated
† Fever type: Intermittent fever presents with elevated temperature but falls to normal (37 .2 °C or below) each day and in case of remittent fever, the
temperature falls each day but not comes to normal. However, in continuous fever, there is little change (0 .3 °C or less) in the elevated temperature during a
24-h period
Out of 720 participants, 462 patients were from inpatients so the classifications were mostly based on objective assessment while hospitalized; however 258
outpatients reported on their febrile history
Table 5 Co-seropositivity of dengue, malaria, Chikungunya with rickettsial illnesses and Coxiella burnetii
n (%)
Any two rickettsial illnesses Typhus group Spotted fever 3 (0.4)
Spotted fever Scrub typhus 45 (6)
Typhus group Scrub typhus 1 (0.1)
Coxiella burnetii with any two rickettsial illnesses Typhus group Scrub typhus 1 (0.1)
Spotted fever Scrub typhus 1 (0.1)
Coxiella burnetii with any one rickettsial illnesses Scrub typhus 3 (0.4)
Chikungunya with any two rickettsial illnesses Spotted fever Scrub typhus 5 (1)
Scrub typhus 1 (0.1)
Dengue with any two rickettsial illnesses Spotted fever Scrub typhus 5 (1)
Dengue with any one rickettsial illnesses Typhus group 1 (0.1)
Spotted fever 9 (1)
Scrub typhus 10 (1)
Dengue Coxiella burnetii 1 (0.1)
Malaria (P. falciparum) Coxiella burnetii 1 (0.1)
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evidence of Chikungunya virus in Bangladesh [49]. During
our study period in December 2008, the first Chikungunya
outbreak had been reported from Rajshahi and Chapiana-
wabganj districts of Bangladesh [14]. However, we identi-
fied Chikungunya cases throughout the year from Khulna,
a district in southern Bangladesh, suggesting Chikungunya
fever was circulating in Bangladesh and in neighbouring
states of India where re-emergence of this virus had
already been reported [49].
Our study had some limitations. This was a hospital
based study, and therefore excluded acute febrile patients
who never visited these hospitals. However, the selected
study sites were the regional referral hospitals and had a
wide catchment area. In addition, the selected pathogens
often result in serious febrile and other clinical pre-
sentations which require hospitalizations or hospital visits.
Therefore, the study hospitals were likely able to capture
most of the febrile-illness causing pathogens that were
targeted.
Secondly, all samples were not tested for all pathogens.
Only samples from febrile patients with joint pain were
tested for Chikungunya virus and only samples collected
from June to November 2009 were tested for Coxiella
burnetii. However, earlier studies demonstrate that joint
pain is an obligatory feature for Chikungunya fever [12]
and C. burnetii has been commonly reported in early
spring and summer months [6, 50].
Thirdly, the methods used for rickettsial diagnosis
were primarily serological tests. There were no paired
samples to evaluate the changes of titres for rickettsial
serological laboratory analysis. However, a single IFA
titre of > 64 which has been used as a cut-off for the
diagnosis of rickettsia infection in this study, would
likely to confirm the presence of rickettsia infection in
Bangladesh. Some of these positive serological tests
were likely from prior infection, and might not be the
cause of the presenting febrile illness including those
illnesses leading to death. Although this testing strategy
may have overestimated active rickettsial infections, the
high IFAT titers detected in many patients during the
study period were strongly suggestive of acute infections.
On the other hand, the culture-based approach likely
underestimated the prevalence of leptospirosis and barto-
nellosis. However, these culture methods were important
for confirmation and identification of specific Bartonella
or Leptospira species.
Conclusions
Rickettsial diseases are a common cause of febrile ill-
ness in Bangladesh. These febrile patients are either left
undiagnosed or misdiagnosed (for example, enteric fever).
The feasibility of using more expensive reliable rickettsial
diagnostics such as IFAT (USD 24.60 per test) or PCR (cost
variable) tests in the local context needs to be weighed
against the alternative of more widespread prescription of
available inexpensive antibiotics. Although the low cost of
the Weil-Felix test makes it attractive to laboratories in
Bangladesh, the low sensitivity and specificity means that it
provides limited sound guidance to clinical decisions. Popu-
lation based studies would help identify the local environ-
mental and socio-cultural factors behind these identified
infections to adopt appropriate interventions. Clinical man-
agement guidelines for febrile patients should be revised
considering other prevailing causes of febrile illness in the
country in addition to malaria and dengue.
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